NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock

$0.30+0.00 (+0%)
Updated Feb 11, 2025
QNRX Price
$0.30
Fair Value Price
N/A
Market Cap
$1.51M
52 Week Low
$0.28
52 Week High
$6.18
P/E
N/A
P/B
0.28x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.70M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.09
Operating Cash Flow
-$9M
Beta
1.56
Next Earnings
Mar 11, 2025
Ex-Dividend
N/A
Next Dividend
N/A

QNRX Overview

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine QNRX's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
QNRX
Ranked
Unranked of 558

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important QNRX news, forecast changes, insider trades & much more!

QNRX News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how QNRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QNRX is good value based on its book value relative to its share price (0.28x), compared to the US Biotechnology industry average (4.8x)
P/B vs Industry Valuation
QNRX's cash and short-term investments ($10.31M) cannot cover QNRX's cash burn for the next year ($18.90M), once increasing cash burn (113.64%) is accounted for
Interest Coverage Financials
QNRX's short-term assets ($10.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more QNRX due diligence checks available for Premium users.

Valuation

QNRX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-137.9x
Market
31.02x

QNRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.28x
Industry
4.8x
QNRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QNRX's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.3M
Profit Margin
0%
QNRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$11.4M
Liabilities
$5.9M
Debt to equity
1.09
QNRX's short-term assets ($10.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QNRX's short-term assets ($10.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QNRX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
QNRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.2M
Investing
$2.6M
Financing
-$149.9k
QNRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

QNRX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
QNRX$1.51M-0.33%N/A0.28x
MBRXD$1.52M-27.98%-0.04x0.20x
PALID$1.50M-2.59%-0.08x0.23x
TNFAF$1.48M+4.26%-0.04x0.09x
WINT$1.44M+13.48%-0.01x0.33x

Quoin Pharmaceuticals Stock FAQ

What is Quoin Pharmaceuticals's quote symbol?

(NASDAQ: QNRX) Quoin Pharmaceuticals trades on the NASDAQ under the ticker symbol QNRX. Quoin Pharmaceuticals stock quotes can also be displayed as NASDAQ: QNRX.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.

What is the 52 week high and low for Quoin Pharmaceuticals (NASDAQ: QNRX)?

(NASDAQ: QNRX) Quoin Pharmaceuticals's 52-week high was $6.18, and its 52-week low was $0.28. It is currently -95.15% from its 52-week high and 6.76% from its 52-week low.

How much is Quoin Pharmaceuticals stock worth today?

(NASDAQ: QNRX) Quoin Pharmaceuticals currently has 5,049,720 outstanding shares. With Quoin Pharmaceuticals stock trading at $0.30 per share, the total value of Quoin Pharmaceuticals stock (market capitalization) is $1.51M.

Quoin Pharmaceuticals stock was originally listed at a price of $15,900.06 in Aug 1, 2016. If you had invested in Quoin Pharmaceuticals stock at $15,900.06, your return over the last 8 years would have been -100%, for an annualized return of -74.33% (not including any dividends or dividend reinvestments).

How much is Quoin Pharmaceuticals's stock price per share?

(NASDAQ: QNRX) Quoin Pharmaceuticals stock price per share is $0.30 today (as of Feb 11, 2025).

What is Quoin Pharmaceuticals's Market Cap?

(NASDAQ: QNRX) Quoin Pharmaceuticals's market cap is $1.51M, as of Feb 12, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quoin Pharmaceuticals's market cap is calculated by multiplying QNRX's current stock price of $0.30 by QNRX's total outstanding shares of 5,049,720.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.